DISTRIBUTION OF A CROSS-REACTIVE IDIOTYPIC SPECIFICITY IN INBRED STRAINS OF MICE by Pawlak, Laura L. & Nisonoff, Alfred
DISTRIBUTION  OF  A  CROSS-REACTIVE IDIOTYPIC  SPECIFICITY 
IN  INBRED  STRAINS  OF  MICE* 
BY LAURA L.  PAWLAK ANI) ALFRED NISONOFF 
(From the Department of Biological  Chemistry, University of Illinois College of Medicim, 
Chicago, Illinois 60680) 
(Received for publication 10 November 1972) 
Idiotypic determinants are present on myeloma proteins (1)  and on induced anti- 
bodies (2,  3),  where they are characterized by their association with antibody of a 
given specificity.  Shared  determinants are  ordinarily not detectable in nonspecific 
IgG,  1 in preimmune serum, nor in antibodies of other specificities from the same ani- 
mal. As would be predicted, idiotypic determinants are localized  in the Fab fragment 
of immunoglobulin molecules (6).  In many antibodies the region of  the active site 
appears to be an important idiotypic determinant, as shown by the capacity of specific 
haptens to inhibit the reaction with anti-idiotypic antibody (7-10).2 Complete block- 
ing by haptens is generally not observed, which suggests the presence of additional 
idiotypic determinants on the Fab fragment. This is supported by the capacity of Fab 
fragments from some, although not all, immunoglobulins  to form specific precipitates 
with  their  anti-idiotypic antibodies  (11);  this  property  would  require  antigenic 
multivalence. 
Mice of an inbred strain are frequently observed to produce antibodies of a given 
specificity with shared idiotype. Intrastrain cross-reactions have been observed among 
the anti-phosphorylcholine (anti-PC)  3 antibodies of different BALB/c mice (12, 13), 
the  anti-p-azobenzoate antibodies of A/J  mice  (14),  A/J  anti-p-azophenylarsonate 
(anti-At)  antibodies  (14),  BALB/c  anti-p-azobenzoate antibodies  (14),  BALB/c 
anti-oe,l,3-dextran antibodies  (15),  and  A/J  antistreptococcal carbohydrate  anti- 
bodies  (16).  In  contrast,  intrastrain idiotypic  cross-reactions  among  the  anti-p- 
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t Although nonspecific IgG can  sometimes inhibit precipitin  reactions of anti-idiotypic 
antibodies directed to a myeloma protein, each myeloma protein appears to have at least one 
idiotypic  determinant that  is not detectable,  by highly  sensitive methods,  in nonspecific 
IgG (4, 5). 
2 The question of a possible conformational change is considered elsewhere (7). If such a 
change does occur it must be greatly restricted in scope since it does not affect anti-Fab or 
antiallotypic antibodies directed to determinants in the Fab fragment. 
3 Abbreviations used in  this paper: anti-Ar, anti-p-azophenylarsonate; anti-PC, antiphos- 
phorylcholine; B cell, bone marrow-derived cell; BGG, bovine gamma globulin; BSA, bovine 
serum albumin; CRI,  cross-reactive idiotype;  KLH,  keyhole limpet  hemocyanin;  SRBC, 
sheep erythrocytes;  T cell, thyinus-derived cell. 
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azophenylarsonate antibodies of C57BL mice are very weak  (14)  and  other examples 
of poor intrastrain  cross-reactions have been observed.  4 
The  strongest  intrastrain  cross-reactions  so far noted  in  our  laboratory  are 
those of anti-Ar antibodies of A/J  mice; the antibodies of eachof more than  100 
individual  animals  tested  have  been  found  to  share  idiotypic  specificity.  The 
idiotype  of A/J  anti-Ar antibodies is,  however,  present in far lower concentra- 
tions in the anti-Ar antibodies of certain other  strains of  mice (14,  17,  and  the 
present  investigation).  This  suggested  that  idiotype  could  represent  a  genetic 
marker  for  the  variable  regions of mouse  immunoglobulin  polypeptide  chains 
(14,  17),  and  the  information  was  used  to  demonstrate  linkage of  the  anti-Ar 
idiotype to heavy chain allotype (17-19).  In this paper we present quantitative 
data  on cross-reactions  of the A/J  anti-Ar idiot3~e in  16  inbred  strains  and 4 
congenic strains  of mice. The data  are discussed  in  terms  of the  correlation of 
idiotype with histocompatibility type and allotype. 
Materials and Methods 
Inbred Mice.--With the exception of AL/N and  BC9 mice, which were the gift of Dr. 
Michael Potter, all inbred,  F1, and congenic mice were obtained from the Jackson Labora- 
tory, Bar Harbor, Maine. The BC9 strain was obtained by introgressively backcrossing the 
IgCH complex locus of strain AL/N mice onto a  BALB/c background.  After nine backcross 
generations the mice were rendered homozygous for the heavy chain allotype of the AL/N 
strain.  A.Sw/Sn and A.By/Sn are congenic resistant strains with the H-2 type of Sw or By 
on a strain A background.The B 10.A strain has the H-2 type of an A mouse on a C57BL/10J 
background. 
Preparation of Antisera.--The  preparation  of  the  antigen,  keyhole  limpet  hemocyanin 
(KLH)-p-azophenylarsonate,  has been  described  elsewhere  (14).  Mice were immunized  by 
injecting intraperitoneally 500 ~zg of this conjugate, emulsified in complete Freund's adjuvant, 
twice with an interval of 2 wk between injections. This was followed by two biweekly intra- 
peritoneal injections of the antigen in Freund's incomplete adjuvant. Subsequently, boosters 
were given as necessary at intervals of at least 1 mo to maintain a high titer of anti-At anti- 
bodies.  An ascites fluid was induced by the method of Sommerville (20) in those mice whose 
antibodies were to be used for the production of anti-ldiotypic antisera. The amount of anti-At 
antibody in each antiserum  or ascites fluid was determined  by  the quantitative precipitin 
reaction using 20-50/zl portions of antiserum per test. The optical density" at 280 nm of the 
washed precipitate, dissolved in 0.04 M NaOH, was determined in quartz microcells. 
Methods used  for  the preparation  and  absorption  of rabbit  anti-idiotypie antisera,  and 
for the specific purification of the mouse anti-Ar antibody to be labeled and used in indirect 
precipitation tests, have been described (14). Binding of the ae~I-labeled,  specifically  purified 
anti-Ar antibody to its anti-idiotypic antibodies was quantified by an indirect precipitation 
(antiglobulin) assay, using 0.01/zg of labeled ligand per test (14). In each series controls were 
run in which rabbit  antiovalbumin antiserum was substituted  for anti-idiotypic antiserum. 
The  blanks  thus  obtained  (6-10%)  were  subtracted  from  experimental  data.  The  net 
percentage  of  radiolabel  precipitated  in  the  absence  of  inhibitor  was  40%  in  one 
system and  55% in the other.  In addition  to the tests for idiotypic specificity  described in 
Table I,  each rabbit anti-idiotypic antiserum  was assayed  for its capacity to bind 0.01  #g 
of 12514abeled nonspecific IgG. Percentages of label precipitated varied from 6 to 9%. 
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When necessary the specific removal of anti-Ar antibodies from mouse antisera was ac- 
complished by using as the immunoadsorbent Sepharose 4]3 to which bovine gamma globulin 
(BGG)-p-azophenylarsonate was  coupled by  the  cyanogen bromide  technique  (21). The 
weight of antigen coupled was approximately 5 mg/cm  ~ of packed Sepharose. Control ad- 
sorptions were always run with unconjugated Sepharose. 
TABLE I 
Idiotypic Specificity of Absorbed Rabbit Antiserum Directed to Anti-Ar Antibody of Mouse 182 
Wt ratio unlabeled  usi_labele  d 
Unlabeled  inhibitor  SpecificitYinhibitorsOf  Antibody  content  inhibitorligandtO  l~SI-labeled  ligand  ppt.* 
% of control~ 
2X 103:4X 103  98  ±  2  Preimmune serum from 
donor mouse (10/~l) 
Hyperimmune donor 
serum 
IgG (A/J) 
Hyperimmune A/.[ 
serumLI 
Hyperimmune A/J 
serum H 
BSA (2 rag) 
Hyperimmune donor¶ 
serum (adsorbed) 
Control adsorption** 
Nonspecific 
Anti-Ar 
Nonspecific 
Anti-KLH 
Anti-KLH-p- 
azoben- 
zoate 
20--40 #g IgG 
(estimated) 
0 02 #g§ 
0.2 #g 
2 mg 
1 mg 
1 mg§ 
2:1 
20:1 
2  X  105:1 
105:1 
105:1 
1  /zl 
10 /~g 
2  X  105:1 
103:1 
46  ±  6 
0 
59±2 
63±0 
844-  1 
93-4-5 
82  4-7 
* 40% of the labeled ligand  (specifically purified anti-Ar antibody)  was precipitated  by 
the antiserum in the absence of inhibitor. 
:~ 4- average deviation. 
§ Refers to content of precipitable antihapten antibody. 
1] Pooled hyperimmune serum from 10 mice other than donor. 
¶ With Sepharose-BGG-Ar. 
** With Sepharose. 
RESULTS 
Specificity of Absorbed Rabbit A ntisera for Idiotypic Determinants.--Evidence 
has been presented elsewhere  (14,  17)  for the anti-idiotypic specificity of the 
absorbed rabbit anfisera prepared  against anti-Ar antibodies of  mice 413 and 
126.  The data in Table I  provide similar evidence for antibody directed to the 
anti-Ar  antibody of  mouse  182.  Hyperimmune serum  of  the  donor  mouse 
strongly inhibited the  binding of  0.01  ~g  of  125I-labeled  specifically purified 
antibody to its rabbit anti-idiotypic antibodies. An amount of  unlabeled anti- 
serum containing as little as 0.02  ~g of precipitable anti-Ar antibody caused 
significant inhibition. In contrast, 10 ~1 of preimmune serum (containing about 
20-40 pg  of  IgG)  had  no inhibitory effect.  Adsorption of  the  hyperimmune 
serum with  Sepharose-BGG-Ar to  remove  antihapten antibody removed  all 
inhibitory capacity,  whereas  treatment with  the  same  amount of  unconju- 858  DISTRIBUTION  OF  AN  II~IOTYPE  IN  INBRED  MICE 
gated  Sepharose had no significant effect.  Pooled hyperimmune anti-KLH or 
anti-KLH-p-azobenzoate antisera  from  A//J  mice  caused  only  37  and  16% 
inhibition when tested  at the level  of 1 mg of precipitable  antibody, i.e.,  with 
a ratio of unlabeled ligand of 10  ~: l. Two mg of IgG of the  A/J  strain  caused 
41%  inhibition;  bovine serum  albumin  (BSA) was noninhibitory. Thus,  on a 
weight basis  the unlabeled anti-Ar antibody' of the donor mouse, no.  182, was 
more than 5  X  104 times as effective as an inhibitor as each of the other inl- 
munoglobulins or BSA. The results indicate that the absorbed rabbit antiserum 
recognizes idiotypic determinants.  Similar quantitative  results  have  been ob- 
tained with other anti-idiotypic antisera (17, 22). 
An additional test for idiotypic specificity was carried out with the antiserum 
against anti-Ar antibodies from mouse 126. Equal volumes of preimmune serum 
from each of 10 mice of each inbred strain investigated (see Tables III and IV) 
were pooled. 50 #1 of the pooled serum was then  tested  as an inhibitor in the 
indirect assay system. The percentage of labeled  ligand bound varied from 81 
to 110% of the control value. The amount ol IgG in 50 #1 is roughly 100-200 
#g; nevertheless,  the maximum degree of inhibition was much lower than that 
caused  by 0.02  #g of  the  unlabeled  donor antibody.  This  indicates  that  the 
cross-reactive  idiotype  is  not present  in  appreciable  concentration  in  preim- 
mune serum of any of the strains of mice investigated. 
A  mlmber  of  additional  tests  were  carried  out  by  immunoadsorption  to 
ascertain  whether  the  inhibitory  capacity  resides  uniformly  in  the  anti-Ar 
population. Antisera from three mice of each strain  which  showed  significant 
inhibitory  capacity  (A/J,  A/He,  AL/N,  A/WySn, A.By/Sn,  A.Sw/Sn)  and 
antisera from all of the BC9 mice were treated individually with the Sepharose- 
B(iG-Ar  adsorbent.  In  every instance  the  anti-Ar  antiserum  was  no  longer 
effective as an inhibitor after the inmmnoadsorption; the maximuni degree of 
inhibition by 20 #1 of adsorbed serum was 17 9;. 
hzlraslrain  Idiolypic  Cross-Reaclions of A/J Anli-Ar A~zl~bodies.  The  data 
in  Table  II summarize  the  reactions  of  anti-Ar  antibodies  from  individual, 
hyperimnmne  A/J  mice  with  three  anti-idiotypic  antisera,  prepared  against 
specifically purified anti-Ar antibodies of mice  126, 182, and 413. Reactivity of 
Anti-Ar antibodies from different mice with anti-idiotypic antisera was quanti- 
fied  by measurement  of the  capacity"  of each  hyperimmune antiserum  to in- 
hibit the binding of 0.01 #g of ~2aI-labeled anti-Ar antibody" of the donor mouse 
to its anti-idiotypic antibodies. Inhibitory" capacity is expressed  in terms of the 
anmunt of unlabeled  precipitating  anti-Ar  antibody necessary to  cause  50% 
inhibition  of binding.  This  value  is  obtained  by interpolation  on  a  curve  of 
percent  inhibition  vs.  amount  of unlabeled  inhibiting  antibody present.  The 
experimental  error in  the interpolated value is estimated  to be of the order of 
20 ~;i. 
Individual  antisera  were  tested  as  inhibitors  of two,  and  in  some cases  all 
three,  of the anti-idiotypic antisera  (Table II). For this reason each antiserum L.  L.  PAWLAK  AND  A.  NISONOFF  859 
TABLE II 
lntrastrain Idiotyplc Cross-Reactions of A/J Anti-Ar Antibodies 
Donor of anti-Ar  Wt of A/J anti-Ar antibody needed for 50%  Median  System  antibody (mouse no.)  inhibition  of binding*  value 
/~g  ~g 
A  126  (0.02) ~, 0.02b, 0.02e, 0.025d, 0.03e, 0.04f, 0.05g,  0.15 
0.05h, 0.05i, 0.1j, 0.15k, 0.21, 0.2m, 0.3~, 0.30, 
0.35p, 0.4q, 0.45r,  0.Ss, 0.St, 0.Su 
B  182  (0.02)g,  0.05~,i,o,  0.08f,  0.15e,h,  0.2  ......  0.30 
0.3j,k,1, p,q,t, 0.35c, 0.4a,u, 0.45n,r, 0.6b 
C  413  (0.05)f, 0.06e, 0.1a,  0.2b,  0.3e,d,h,i,  0.5e,  0.6k,  0.30 
1.3r, 1.91 
* 0.01 #g of 1%I-labeled, specifically purified  anti-Ar antibody of the donor mouse was 
used in the indirect precipitation test (see Methods). Whole sera were tested as inhibitors; 
data are expressed as weights of precipitable anti-Ar antibody required for 50% inhibition. 
Each value represents an individual A/J mouse, which is designated by a letter of the al- 
phabet shown as a  subscript to numerical  values in  the table. Unlabeled  antiserum from 
each donor mouse was also tested; these values are given in parentheses. 
is identified by a letter of the alphabet, included as a  subscript after the corre- 
sponding  experimental  value  in  Table  II.  The  value  for  unlabeled  anti-Ar 
antibodies of the donor mouse in each system is given first and in parentheses. 
Anti-Ar antibody from each mouse  tested was a  potent inhibitor of each of 
the  three anti-idiotypic antibody preparations  (Table II),  although consider- 
able variation is seen in the amounts  of unlabeled antibody required for 50% 
inhibition. However,  even  the highest values (0.5-1.9/~g)  are extremely small 
when compared with the milligram quantities of unrelated antibodies which fail 
to give 50 %  inhibition (Table I). In nearly all cases unlabeled antibodies from 
mice other than  the donor were less effective as inhibitors than  the unlabeled 
donor antibodies. 
By noting the letter subscript associated with each value one can  ascertain 
whether the antibodies of the various mice fall in the same order of effectiveness 
with each of the three sera tested  (although not all of the group was tested in 
system C, Table II). It is apparent that there is some correlation in the order of 
effectiveness but also marked deviations, e.g. mice b, c, and d, whose antibodies 
are very effective in system A but relatively less effective in system B. Antisera 
from mice j, k, 1, n, q, r, t, and u were among the less effective inhibitors in each 
system  in  which  they were  tested.  Antibody from  mouse  a  was  a  potent  in- 
hibitor in each system. In the three systems studied the median values for all 
mice (last column Table II) are 7.5, 15, and 6 times as great, respectively, as the 
value for the amount of unlabeled donor antibody required for 50% inhibition. 
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mice studied clearly fell into two groups in terms of the idiotype of their anti-Ar 
antibodies. One group synthesized anti-Ar antibodies bearing the cross-reactive 
idiotype (CRI) in concentrations comparable to those found in the A/J strain. 
In the other group the amounts of CRI produced were far smaller. There is a 
clear distinction between the groups and we have so far not discovered strains 
producing intermediate concentrations of CRI. 
Data on strains, in addition to A/J, which did synthesize idiotypically cross- 
reacting antibodies are shown  in Table  III.  These  strains  are A/He,  AL/N, 
and  A/WySn; two  congenic  strains  (A.By/Sn, A.Sw/Sn)  in  which  the  histo- 
compatibility genes of the indicated strain have been introduced into a strain A 
background;  and  the  BC9  congenic  strain,  bearing  the  AL/N  allotype on  a 
BALB/c background. 
The values in the fourth column of Table III show the weights of precipitable 
anti-Ar antibodies from individual mice of the specified strain that caused 50% 
inhibition of binding of the labeled donor antibody. The median values  (fifth 
column)  and range are quite similar for each of the pure and congenic strains. 
TABLE  III 
Inhibition of Binding of 125I-Labeled A nti-A r Antibody of Mouse 126 to Its A nti-Idiotypic A nil- 
body. Inhibitors:  Anti-Ar Antisera from Mice of Strains Producing  the Cross-Reacting 
Idiotype 
Heavy chain  Wt of antibody required for 50%  Median  Strain  linkage group*  H-2 type  (allotype)  inhibition of binding,  +  value 
A/He  a  4 
AL/N  a(a)§ 
A/WySn  a  4 
A.Sw/Sn (congenic)  a 4 
A.By/Sn (congenic)  a 4 
BC9 (congenic)  a (4) § 
#g  ~g 
a  0.05,  0.05,  0.06,  0.08,  0.08,  0.1,  0  10 
0.1,  0.1,  0.1,  0.1,  0.2,  0.3,  0.4 
a  0.03,  0.04,  0.05,  0.05, 0.08,  0.08,  009 
0.08, 0.1, 0.4, 0.4, 0.5, 0.8,  1.1, 
1.2 
a  0.05, 0.08, 0.1, 0.1,  0.15, 0.2, 0.4,  0  17 
0.4, 0.5, 0.9 
s  0.05,  0.05,  0.05,  0.05, 0.05,  0.1,  0.17 
0.15,  0.15, 0.2,  0.25,  0.25,  0.3, 
0.3, 0.35, 0.35, 0.35, 0.4 
b  0.1, 0.15, 0.15, 0.3, 0.35, 0.45, 0.5  030 
d  0.05,  0.2,  0.25, 0.35,  0.4,  0.45,  037 
0.5, 0.5 
* The abbreviations used for the heavy chain linkage groups are taken from Lieberman 
and Humphrey (24). 
:~ See Table II, first two sentences  of footnote *. The weight of unlabeled antibody from 
the autologous (donor)  mouse  required for 50%  inhibition was 0.02 #g. 
§ The immunoglobulin  of the AL/N strain has one additional determinant, 18, which  is 
not assigned  to a  particular immunoglobulin  class. A separate designation for the  linkage 
groups of the AL/N strain was not assigned by Lieberman and Humphrey (24). It is placed 
in a separate group by Herzenberg  et al. (27). L.  L.  PAWLAK AND  A.  NISONOFF  861 
The  median value for the BC9  strain, 0.36 #g,  is slightly more than  twice as 
great as that for isologous A/J mice (Table II). This difference, although small, 
is probably significant since more than  0.2/zg of antibody was required, with 
seven of the eight BC9 antisera tested, whereas less than 0.2 #g of A/J antibody 
is required for 50% inhibition in most instances. We consider other differences 
among the strains listed in Table III to be of marginal significance. In addition, 
with the possible exception of the BC9 group, mice of each strain produced the 
cross-reactive idiotype in a  concentration, on  the average, comparable to that 
of  the  A/J  strain  (to  which  the  donor  mouse  belonged). Also,  within each 
strain  there  is  a  considerable  spread  of  values  for  individual  mice  but  in 
no  instance was  more  than  1 #g  of unlabeled antibody required  for 50%  in- 
hibition of binding.  Genetic relationships among these strains of mice will be 
considered in  the Discussion. 
Table IV presents inhibition data on anti-Ar antibodies from strains of mice 
which produced little or no antibody with the cross-reactive idiotype. A  single, 
relatively large  amount  of unlabeled  antibody  (10  #g)  was  tested  for  its in- 
hibitory capacity. From most strains listed in Table IV, none of the mice pro- 
TABLE IV 
Inhibition  of Binding  of 12aI-Labeled Anti-Ar  Antibody  of Mouse 126  to Its Anti-Idiotypic 
Antibody  by  Anti-At  Antisera  from  Strains  Producing  Little  Cross-Reactive Idiotype 
Heavy chain  125I-labeled ligand bound in presence  of  Median  Strain  linkage group  H-2  type  (allotype)  inhibitory antiserum*  value 
%  of control$  % 
BALB/c  a 1  d  63, 72, 85, 89, 92, 98, 99, 99, 102, 103  95 
CBA  a 1  k  97, 97, 97, 97, 98, 98, 99, 99, 100, 102  98 
C3H  a t  k  76, 89, 89, 95, 96, 96, 97, 97, 99  96 
C57BR/cdJ  a I  k  65, 66, 68, 76, 79, 88, 90, 92, 92, 96  84 
C57BL/6J  a 2  b  41§, 46§, 51, 53, 60, 76, 77, 85, 87, 91  68 
LP/J  a 2  b  95, 96, 97, 97, 98, 98, 99, 100, 100, i00  98 
SJL/J  a 2  s  75, 88, 92, 92, 95, 95, 96, 96  94 
SM/J  a 2  v  67, 67, 70, 72, 79, 79, 85, 94, 95, 101  79 
B10.A  a 2  a  2411 , 35l[  , 4511  , 58, 64, 67, 68, 73, 83, 85  66 
DBA/2J  a s  d  35¶, 40¶, 43¶, 53, 53, 54, 55, 65, 66, 72,  60 
73, 73, 76, 77 
RF/J  a s  k  65, 71, 72, 72, 73, 76, 77, 77, 78, 106  75 
SWR/J  a 3  b  64, 91, 92, 95, 96, 97, 98, 99, 103, 106  97 
NZB  a 4  d  85, 91, 92, 94, 95, 98, 99, 99, 100, 101  97 
AKR/J  a (4)  k  86, 87, 94, 95, 95, 96, 96, 97, 99, 105  96 
* Each serum  contained 10 #g of precipitating anti-Ar antibody. The average deviation 
from the mean 2 expressed as percent of control, was 4%. 
Each value is an average of a duplicate determination. 
§ 6 and 6.5/zg of anti-Ar antibody required for 50% inhibition. 
]I 2, 3, and 5.5/zg of anti-Ar antibody required for 50% inhibition. 
¶ 6-6.5/zg of anti-Ar antibody required for 50% inhibition. 862  DISTRIBUTION  OF  AN  IDIOTYPE  IN  INBRED  MICE 
duced antibodies that caused 50%  inhibition of binding when  tested at the 10 
/,g level. The only" exceptions were the DBA and C57BL strains and the B10. A 
congenic mice,  carrying  the H-2  type  of strain A  on  a  C57BL  background. 
Even in these strains the antisera of most mice failed to cause 50%  inhibition; 
and for those antisera which did  the weights of antibody needed were high as 
compared with  the strains listed  in Table  III.  Many  of the strains produced 
antibodies  that  appear  almost completely non-cross-reactive,  as indicated  by 
the median values in the last column of Table IV. 
The  above  results  were  confirmed  with  another  anti-idiotypic  antiserum, 
directed to the anti-Ar antibody of mouse 182  (Table V). In this set of experi- 
ments, each anti-Ar antiserum was tested as inhibitor at a single concentration, 
using  an  amount  of  antiserum  which  contained  1  /ag  of precipitable  anti-Ar 
antibody. 
TABLE  V 
Inhibition  of Binding  of 0.1 Izg  of lzaI-Le, beled Anti-Ar Antibody  of Mouse  182  to Its Anti- 
[diotypic Antibodies by A nti-A r A ntisera j)'om  Mice of Strains Other than A/J 
12~I labeled ligand bound 
tteavy chain  No.  of  in presence of inhibitory 
Strain  linkage  group  1I-2 type  antiserum* 
/a lotype)  mice tested 
Range  Median value 
% of com;ol} 
A/He  a 4  a  10  34  47  41 
AI<N  a(4) §  a  10  36 -56  39 
A/WySn  a 4  a  10  35  46  43 
A.Sw/Sn  (congenic)  a 4  s  10  34-52  43 
A.By/Sn  (congenic)  a 4  b  7  43  53  48 
BC9  (congenic)  a(4)§  d  5  43  60  49 
BALB/e  a I  d  10  85  103  95 
CBA  a t  k  10  101-111  106 
C3H/J  a 1  k  9  92-105  102 
C57BR/cdJ  a I  k  10  80-108  96 
C57BL/6J  a 2  b  10  72  103  86 
LP/J  a ~  b  10  94  110  101 
SJL/J  a 2  s  8  93-107  99 
SM/J  a 2  v  10  7%104  90 
B10.A  (congenic)  a 2  a  10  50-98  90 
DBA/2J  a a  d  10  72--99  87 
RF/J  a :~  k  10  82  93  89 
SWR/J  a:;  b  10  88  97  93 
NZB  a 4  d  10  93-104  101 
AKR/J  a (4)  k  10  93-103  99 
* The  amount  of  each  serum  tested  contained  1  #g  of precipitating  anti-Ar  antibody. 
:~ Each  value  is  an  average  of a  duplicate  determination.  The  overall  average  deviation 
from  the  mean,  expressed  as  percent  of  control,  was  5.7c/~. 
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The results  are virtually the same  as  those  obtained with  the  other anti- 
idiotypic antiserum. Anti-Ar antisera from each of the  A strains and the con- 
genic strains A. By/Sn and A.Sw/Sn were inhibitory. Anti-Ar antibody of the 
BC9 strain,  bearing the allotype marker of AL/N on a BALB/c background, 
was also a strong inhibitor. All other strains produced anti-Ar antibodies that 
were noninhibitory or that gave a marginal degree of inhibition. 
Quantitative Inhibilory Capacity of Antibodies from F1 Mice.--Fig.  1 shows 
data  on  the  interaction with  anti-idiotypic  antiserum  of  anti-Ar  antibodies 
prepared in two Ft strains, C57BL X  A/J and BALB/c X  A/J.  The data are 
presented as  the  weight of unlabeled precipitable anti-Ar  antibody required 
for 50 %  inhibition of binding.  Although nearly all antibody preparations are 
capable  of inhibiting  the  anti-idiotypic  antibodies,  the  individual  sera  vary 
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FIO. 1. Amounts of unlabeled, precipitable anti-Ar antibody from individual mice required 
for 50~ inhibition of binding of 0.01  #g of  125I-labeled  anti-Ar antibody of A/J mouse 126 
to its rabbit anti-idiotypic antibodies. Each point represents an individual mouse. Antibodies 
from  all  mice  of  the  A/J  strain  caused  more  than  50%  inhibition.  Antisera  from  3 
F1 (C57BL X  A/J) and 1 F1  (BALB/c N  A/J) mouse, each containing 2/~g of precipitable 
antibody, failed to cause 50% inhibition. 864  DISTRIBUTION OF  AN  IDIOTYPE  IN  INBRED  MICE 
markedly on  a  quantitative  basis;  many are  equally  as potent,  on  a  weight 
basis,  as  A/J  antibodies,  whereas  others  are  relatively  ineffective,  although 
significant  inhibitory  capacity  is  observed  in  nearly  all  preparations  when 
tested at levels of 1-2 #g. 3 of 16 C57BL )< A/J mice and  1 of 21  BALB/c  X 
A/J mice produced antibodies that caused less than 307i  inhibition when 2 /~g 
was tested. 
DISCUSSION 
It is possible to consider linkage of idiotype  to allotype or  to H-2  type at 
two levels. One is the linkage  observed in  laboratory studies,  for example in 
congenic  mice;  the  other  is  any  apparent  linkage  noted  in  different  inbred 
strains.  Before discussing  the present data we will review briefly experiments 
which  have  been carried  out  with  congenic  or  recombinant-inbred mice and 
which bear on linkage of idiotype to allotype. 
In the case of the anti-Ar idiotype very close linkage to heavy chain allotype 
was observed in all mice of the BC9 strain, which have the heavy chain allotype 
of the AL/N strain on a BALB/c background (17-19). The gene(s) controlling 
anti-Ar idiotype must therefore be closely linked  to genes encoding Ca regions 
of  mouse  immunoglobulin  pobnpeptide  chains.  Similarly,  linkage  between 
allotype and idiotype was demonstrated by Blomberg et al. (15) in recombinant- 
inbred strains.  Their results with congenic mice were, however, not  consistent 
with  close  linkage  and  were  explained  on  the  basis  of a  crossover.  Sher  and 
Cohn (23) found that two congenic mice bearing the heavy chain allotype of the 
AL/N strain on a BALB/c background produced anti-PC antibodies, some  of 
which  were  not  reactive  with  an  anti-idiotypic  antiserum  which  recognizes 
essentially  all  anti-PC  antibodies  produced  by normal  BALB/c  mice.  5 This 
finding would indicate either that there is close linkage between AL/N allotype 
and the idiotype expressed, i.e. that the non-cross-reacting idiotype is charac- 
teristic of AL/N mice, or, conceivably, that the congenic strain produces anti- 
PC antibodies only of BALB/c origin, some of which possess other non-cross- 
reacting  anti-PC  idiotypes,  which  are  sometimes observed  in  BALB/c  mice 
(12). 
The present investigation was concerned with the association of idiotype with 
allotype or H-2 type among different inbred strains and in congenic mice. It is 
evident,  first,  that  there  is no  linkage  of the  anti-Ar  idiotype  to  H-2  histo- 
compatibility type. This is shown by results obtained with the congenic B10. A 
strain. Despite the fact that these mice have the tt-2 type of the A strain (on a 
5 Linkage of the anti-Ar idiotype to allotype was shown by the presence of the charac- 
teristic AL/N idiotype in eongenic mice bearing the AL/N allotype on a  BALB/c back- 
ground. Linkage of the BALB/c anti-PC idiotype to allotype was b~sed on the absence of 
the idiotype from some anti-PC molecules  in congenic mice having an unrelated atlotype on a 
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C57BL background),  their anti-Ar antibodies  do  not  exhibit  the  CRI.  Con- 
versely, congenic mice  bearing  the  H-2  type of other  strains  on  a  strain  A 
background (A.Sw/Sn,  A.By/Sn) produced concentrations of CRI compara- 
ble to that of the A/J strain. As previously reported (19), anti-Ar antibodies of 
the BC9 strain, possessing the AL/N allotype on a  BALB/c background, all 
were strongly inhibitory. 
Somewhat different results were reported by Sher and Cohn (23). In BALB/c 
mice,  immunized  with  pneumococcal  C-carbohydrate  conjugated  to  sheep 
erythrocytes (SRBC), the formation of anti-PC plaques is entirely inhibitable 
by  an  anti-idiotypic (anti-S107)  antiserum; in  strain A/WySn, on  the other 
hand, plaque formation is only slightly or not at all inhibitable. However, the 
congenic strain, A. By/Sn, bearing the II-2 type of strain BY on an A/WySn 
background, forms plaques that are inhibitable at an intermediate level. This 
was interpreted as suggesting that the H-2 gene of the BY strain is linked to a 
gene controlling synthesis of an immunoglobulin polypeptide, possibly  V,,  of 
the BY strain, which bears idiotypic determinants recognized by anti-S107. 6 
We would suggest the alternative possibility that the idiotype expressed could 
depend on the nature of the thymus-derived (T) cell membrane of the A. By/Sn 
mice, which in turn is influenced by the H-2 gene. A given type of T cell might 
favor the expression of particular bone marrow-derived (B) cells, i.e. of particu- 
lar idiotypes, either through its mode of presentation of antigen to B cells or by 
humoral factors released. One could then postulate that the A/WySn strain it- 
self possesses B  cells bearing receptors with the S107 idiotype, but that these 
are normally not expressed or are expressed at a  low level as compared with 
other anti-PC idiotypes. Alterations of the T  cell (or conceivably of the B cell) 
membrane, as in the congenic A. By/Sn strain, might permit some expression 
of  the  S107  idiotype.  Some support for  this possibility  is derived from  the 
results obtained by Sher and Cohn (23) with F1 (BALB/c X  A/J) mice. Since 
A/J mice synthesize anti-PC antibodies which entirely lack the S107  idiotype, 
the F1 mice must also have the genetic capability of producing non-cross-re- 
active as  well  as  cross-reactive anti-PC  antibodies.  But  in  fact  nearly  all 
anti-PC  antibodies  synthesized  by the  F1  mice  carried  the  S107  idiotype. 
Thus,  the  expression of the BALB/c idiotype in  these mice was  favored  at 
the expense of the A/J idiotype. This demonstrates  that  the  genetic  capa- 
bility of producing an idiotype is not equivalent to its expression. It seems con- 
ceivable then that the A/WySn strain has  such  genetic information,  which  is 
not expressed in the pure strain,  but is reflected in  the  congenic mice, either 
through  the  mechanism suggested  above or  through  some  other  mechanism 
relatable  to  H-2  type.  Such  an  alternative might eliminate the necessity of 
postulating linkage of V~ to H-2. 
6  This explanation assumes that the BY strain produces the cross-reactive idiotype. The 
BY strain itself cannot be tested since it is no longer available. 866  DISTRIBUTION OF  AN  IDIOTYPE  IN  INBRED  N'[ICE 
The question  of linkage with  respect  to allotype in  the different strains  of 
mice we studied is less clear.  All strains which exhibited CRI, with the excep- 
tion of the closely related AL/N strain  (see Methods), belong to the a  4 heavy 
chain linkage group of Lieberman and Humphrey (24).  However, NZB mice, 
which are in the same linkage group, failed to produce CRI. 
Several  explanations  for  these  results  may be  considered.  A  crossover be- 
tween the gene(s) controlling CRI and the IgCH region may have occurred in 
an  ancestor  of the  NZB  strain.  A  second possibility is  that  the A  and  NZB 
strains  had  a  common ancestor,  that divergence occurred long before the in- 
breeding process was undertaken, 7 and that the V genes have undergone evolu- 
tion since  that time. The fact that the allotype has remained the same could 
reflect a slower rate of evolution of Cu genes or the failure of antisera to detect 
those  changes in  amino  acid  sequence  which  may have  occurred in  the  CH 
region. The fact that NZB mice are of a different H-2 type than the A strain is 
probably not directly relevant  since  congenic mice  of different H-2  types on 
an  A  strain  background produce  CRI.  However,  the  difference  in  H-2  type 
emphasizes the  fact that  NZB  and A  mice may not be  very closely related, 
despite their shared allotype. 
In a  similar context,  the AKR strain, which has the same heavy chain allo- 
type as AL/N  (an  allotype closely related  to  that of A/J  mice),  differs  from 
AL/N in  that  it  fails  to produce CRI. The AL/N strain  is  thought to have 
originated from an outcrossed strain A mouse, whereas the origin of the AKR 
strain appears unrelated to that of A (25). The fact that the AL/N strain, but 
not AKR, has the same H-2 type as A/"] is probably relevant only insofar as it 
may reflect a common origin of the AL/N and A/J strains.  Actually, our data 
would tend to support the conjecture (25) that the AL/N strain has a strain A 
ancestor, since  other strains producing CRI are all closely related to strain A. 
In addition to the AL/N strain, to the BC9 strain which possesses  the AL/N 
allotype, and to the congenic mice with a strain A background, the strains pro- 
ducing CRI are A/He and A/WySn. Both are  of the saine  ailotype and H-2 
type as A/J and both are sublines of the A strain (25). 
One  interpretation  of  these  patterns  of  cross-reactivity  is  that  different 
strains of mice have different sets of germ line  V genes.  An alternative possi- 
bility is that different strains have similar germ line genes but that a regulatory 
gene controls the production of CRI. If so, this gene nmst be closely linked to 
the IgCu locus, as evidenced by the production of CRI by the BC9 mice. 
Of the two interpretations, we would favor as the simplest possibility the view 
that synthesis of CRI is based on the presence of appropriate genes controlling 
V regions of immunoglobulins, and that CRI therefore is a genetic marker for 
the VH region. Its close  linkage  to the IgCu  locus (17--19) is  compatible  with 
this possibility. 
It is relevant that  the NZB  mice were inbred in England. whereas the A strain  was 
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A  striking feature of the results is the clear separation among strains with 
respect to ability to produce CRI.  On a  quantitative basis  all nonproducing 
strains synthesize less  than  1/10 as much of the CRI as those exhibiting the 
idiotype; the actual ratios are probably much smaller. It is evident then that 
each positive strain synthesizes CRI in substantial quantities.  Since we know 
that  the  A/J  strain  is  capable  of producing anti-Ar  antibodies with  a  great 
variety of idiotypes (26),  the preferential biosynthesis of CRI may reflect its 
association  with  an  immunoglobulin  of  relatively high  affinity which,  as  a 
lymphocyte surface receptor, competes effectively for antigen. The question of 
affinity is being investigated. 
The studies with F1 mice demonstrate that, with very few exceptions, nearly 
all such mice (BALB/c X  A/J or C57BL X  A/J)  produce anti-Ar antibodies 
with  CRI.  However,  the  proportion  of the  anti-Ar  population  carrying  the 
idiotype  varies  considerably  among  individuals.  Antibodies  from  many  F1 
mice are as effective, on a weight basis,  as those of the average A/J  mouse; a 
few mice, however, synthesized considerably less  CRI. On the average, the F1 
mice clearly produced more than half as much CRI as  the parent A/J mice 
(Fig. 1). Two alternati,~e interpretations of these results are: (a) The proportion 
of lymphocytes bearing anti-Ar receptors characteristic of the A/J strain varies 
among individual  F1 mice,  but  there is  a  tendency for such  lymphocytes to 
predominate;  (b)  the  numbers  of  lymphocytes  carrying  receptors  charac- 
teristic of A/J or the non-A/J strain are comparable, but the A/J receptors are 
on the average of greater affinity. Which idiotypes are stimulated in an indi- 
vidual mouse would,  in  this case,  be partly a  matter of chance, with higher 
affinity receptors tending to favor the A/J idiotype.  Once established, any set 
of clones might be difficult to replace because memory cells,  present at high 
concentration, would tend to compete effectively for the antigen. 
The results suggest that the failure of BALB/c or  C57BL  mice  to  express 
the cross-reactive anti-Ar idiotype is attributable to a difference, as compared 
with A/J, in germ line V genes rather than to the presence of a regulatory gene 
which  prevents  the  expression of the  cross-reactive anti-Ar idiotype.  Such  a 
gene should have been present  in the F~ mice and suppressed the appearance 
of the idiotype. 
While the presence of certain idiotypes in some  strains of mice but not in 
others is obviously consistent with the presence of large numbers of V genes, 
which differ among strains (theory of multiple germ line  genes), it can also be 
interpreted via somatic mutation. If a gene which encodes a polypeptide chain 
of a particular antihapten antibody can be derived from a germ line gene by a 
small number of mutations it might occur in nearly all mice of a given strain, 
despite  the  necessity for  random  mutation  to  arrive  at  the  required  DNA 
sequence. Mice of another strain,  possessing different germ line genes,  might, 
through mutation, attain an appropriate but different nucleotide sequence by 
a  similar mechanism,  thus accounting for the observed variations in idiotype 
of anti-Ar antibodies among strains. 868  DISTRIBUTION OF  AN  IDIOTYPE IN  INBRED IV[ICE 
SUMMARY 
The  expression  of  an  idiotype  characteristic  of  anti-p-azophenylarsonate 
antibodies of all A/J mice was explored in F1 progeny, in other inbred strains, 
and  in congenic mice.  Of the  strains  tested  only those closely related  to A/J 
produced antibodies  with the cross-reactive idiotype  (CRI). None of the mice 
synthesized intermediate levels of CRI. No relationship between H-2 type and 
idiotype was noted.  Congenic mice with a strain A background but a different 
H-2 type produced CRI in amounts quantitatively equivalent to those of strain 
A  mice.  Conversely, the presence of the H-2 genotype of strain A  on an unre- 
lated background was not associated with the formation of CRI. Nearly all F1 
progeny  of  strain  A  mice  formed  CRI,  indicating  that  failure  of  the  other 
(non-A) parental strain to produce CRI is not attributable  to the presence of a 
gene controlling the  synthesis of a  suppressor of CRI. NZB mice, which have 
the same heavy chain allotype as strain A, but are unrelated in origin, failed to 
produce  CRI,  although  allotype  has  been  shown  to be  linked  to idiotype in 
congenic strains. 
We are  grateful  to Mr.  John O'Brien,  Mr.  Charles  Munter,  and Mr.  Geoff Morris for 
competent  technical assistance. 
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